A prospective pilot study of pharmacogenetic based dosing of 5-fluouracil and Irinotecan in patients with gastrointestinal (GI) malignancies.

Facility

NS/LIJ

Department

Division of Hematology/Oncology, Department of Medicine

Status

Fellow

Category

Clinical Science Research

Start Date

2-6-2021 12:00 AM

This document is currently not available here.

Share

COinS
 
Jun 2nd, 12:00 AM

A prospective pilot study of pharmacogenetic based dosing of 5-fluouracil and Irinotecan in patients with gastrointestinal (GI) malignancies.